What are the causes of hyperbilirubinemia (elevated bilirubin)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Elevated bilirubin levels can be caused by various factors, including hemolysis, impaired conjugation, parenchymal liver disease, or obstruction of the biliary system, and prompt medical evaluation is necessary to determine the underlying cause and appropriate treatment. The liver plays a crucial role in processing bilirubin, converting it from an insoluble (unconjugated) form to a soluble (conjugated) form that can be excreted 1.

Causes of Hyperbilirubinemia

Some of the common causes of hyperbilirubinemia include:

  • Hemolysis, which can lead to an increase in unconjugated bilirubin
  • Impaired conjugation, such as in Gilbert's syndrome, which is an inherited disorder of metabolism that leads to reduced activity of the enzyme glucuronyltransferase 1
  • Parenchymal liver disease, which can cause an increase in conjugated bilirubin
  • Obstruction of the biliary system, which can also lead to an increase in conjugated bilirubin

Importance of Medical Evaluation

It is essential to consult a healthcare provider immediately if elevated bilirubin levels are detected, especially if symptoms such as yellowing of the skin or eyes (jaundice) are present. The healthcare provider will perform a thorough evaluation to determine the underlying cause of the elevated bilirubin levels and provide appropriate treatment.

Treatment Options

Treatment depends on the underlying cause of the elevated bilirubin levels. For example:

  • For Gilbert's syndrome, no treatment is typically needed
  • For hepatitis, antiviral medications may be prescribed
  • For gallstones blocking bile ducts, surgical removal might be necessary
  • For hemolytic anemia, addressing the underlying cause is essential

Recent Guidelines

According to recent guidelines, phototherapy is an effective treatment for neonatal hyperbilirubinemia, and its use can reduce the risk of bilirubin neurotoxicity and the need for exchange transfusions 1. However, it is crucial to follow the guidelines and recommendations for phototherapy to minimize the risks of unintended harm.

Key Takeaways

In summary, elevated bilirubin levels require prompt medical evaluation to determine the underlying cause and appropriate treatment. The liver plays a crucial role in processing bilirubin, and different patterns of elevation (direct vs. indirect bilirubin) can help physicians determine the specific disorder affecting this pathway. Recent guidelines emphasize the importance of phototherapy in treating neonatal hyperbilirubinemia, and healthcare providers should follow these guidelines to minimize the risks of unintended harm.

From the Research

Causes of Hyperbilirubinemia

The causes of hyperbilirubinemia can be attributed to several factors, including:

  • Hemolysis, which is the breakdown of red blood cells, leading to an increased production of bilirubin 2
  • Glucose-6-phosphate dehydrogenase (G6PD) deficiency, a common cause of severe hyperbilirubinemia in neonates 3
  • Disorders of bilirubin metabolism, hepatocellular dysfunction, or biliary obstruction 4
  • Increased bilirubin production rate due to hemolysis, which can lead to an increased risk of bilirubin-induced neurologic dysfunction (BIND) 2

Risk Factors

Certain risk factors can contribute to the development of hyperbilirubinemia, including:

  • Premature birth, as most preterm and more than half of term neonates experience indirect hyperbilirubinemia 5
  • Hemolytic disease, which can cause severe anemia and a rapid rise in total serum bilirubin level 6
  • Genetic profile and bilirubin binding status, which can affect an infant's overall capacity to cope with the resultant tissue bilirubin load 2

Clinical Detection

Clinical detection of hemolysis is crucial in assessing the risk of developing BIND, and can be achieved through:

  • Laboratory tests, such as liver chemistry tests and bilirubin levels 4
  • Imaging modalities, such as hepatobiliary imaging 4
  • Physical examination, including signs of jaundice, such as yellowing of the eyes or skin 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

A Systematic Approach to Patients with Jaundice.

Seminars in interventional radiology, 2016

Research

The effect of ursodeoxycholic acid on indirect hyperbilirubinemia in neonates treated with phototherapy: a randomized clinical trial.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.